Top Pharmaceuticals companies in Spain by Current Liabilities
Spain
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 2.56 B
|
Dec. 31, 2023 | USD 8.61 | 2.23% |
|
Spain |
|
| 2 |
USD 387.50 M
|
Dec. 31, 2023 | USD 9.63 | -2.28% |
|
Spain |
|
| 3 |
USD 220.58 M
|
Dec. 31, 2023 | USD 68.35 | 0.94% |
|
Spain |
|
| 4 |
USD 181.01 M
|
Dec. 31, 2023 | USD 3.65 | -0.60% |
|
Spain |
|
| 5 |
USD 114.39 M
|
Dec. 31, 2023 | USD 3.65 | -1.71% |
|
Spain |
|
| 6 |
USD 105.84 M
|
Dec. 31, 2023 | USD 95.61 | 0.58% |
|
Spain |
|
| 7 |
USD 99.54 M
|
Dec. 31, 2023 | USD 2.67 | -0.53% |
|
Spain |
|
| 8 |
USD 95.83 M
|
Dec. 31, 2023 | USD 3.71 | 0.53% |
|
Spain |
|
| 9 |
USD 18.12 M
|
Dec. 31, 2023 | USD 1.52 | 0.94% |
|
Spain |
|
| 10 |
USD 7.92 M
|
Dec. 31, 2023 | USD 1.81 | -0.12% |
|
Spain |
Frequently Asked Questions
-
Which Pharmaceuticals company in Spain has the highest Current Liabilities ?
The Pharmaceuticals company in Spain with the highest Current Liabilities is Grifols, S.A. (MCE: GRF.MC) at USD 2.56 B.
-
Which Pharmaceuticals company in Spain has the lowest Current Liabilities ?
The Pharmaceuticals company in Spain with the lowest Current Liabilities is Pangaea Oncology, S.A. (MCE: PANG.MC) at USD 7.92 M.
-
What are the top 10 Pharmaceuticals companies in Spain by Current Liabilities ?
The top 10 Pharmaceuticals companies in Spain by Current Liabilities are Grifols, S.A., Almirall, S.A., Laboratorios Farmaceuticos Rovi, S.A., Ercros, S.A., Atrys Health, S.A., Pharma Mar, S.A., Laboratorio Reig Jofre, S.A., Faes Farma, S.A., Oryzon Genomics S.A. and Pangaea Oncology, S.A..
-
What are the bottom 10 Pharmaceuticals companies in Spain by Current Liabilities ?
The bottom 10 Pharmaceuticals companies in Spain by Current Liabilities are Pangaea Oncology, S.A., Oryzon Genomics S.A., Faes Farma, S.A., Laboratorio Reig Jofre, S.A., Pharma Mar, S.A., Atrys Health, S.A., Ercros, S.A., Laboratorios Farmaceuticos Rovi, S.A., Almirall, S.A. and Grifols, S.A..
